Value of CRP/albumin ratio as a prognostic marker of acute pancreatitis: a retrospective study

Rev Esp Enferm Dig. 2023 Dec;115(12):707-712. doi: 10.17235/reed.2023.9345/2022.

Abstract

Introduction: the C-reactive protein (CRP) to albumin ratio is an inflammatory marker that has shown promise in the prognosis of critically ill patients. This study is aimed to assess the value of CRP/albumin ratio to predict severity in acute pancreatitis.

Methods: a retrospective study was performed using a prospectively collected database of patients diagnosed with AP admitted to the Department of Gastroenterology between March 2014 and December 2021.

Results: among 722 patients included in the study, 78.67 % had mild, 15.65 % had moderately severe, and 5.67 % had severe acute pancreatitis. The CRP/albumin ratio was significantly associated with severe AP (OR 1.02; 95 % CI: 1.01-1.03; p < 0.001), and each ten-unit increase in the ratio was associated with a 20 % increased likelihood of severe acute pancreatitis. The area under the ROC curve (AUC) value of the CRP/albumin ratio in severe acute pancreatitis was 0.68 (95 % CI: 0.58-0.77), which was higher than that of the Ranson criteria (0.62). The optimal cut-off value for predicting severe acute pancreatitis was 7.51, with a sensitivity of 63.4 % and specificity of 65.6 %.

Conclusions: despite its low sensitivity and specificity, the CRP/albumin ratio could be used as a complementary marker to the current scoring systems for the initial assessment of acute pancreatitis prognosis. It is easily obtainable and can provide additional prognostic information to clinicians.

MeSH terms

  • Acute Disease
  • Biomarkers
  • C-Reactive Protein* / analysis
  • Humans
  • Pancreatitis* / diagnosis
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Severity of Illness Index

Substances

  • C-Reactive Protein
  • Biomarkers